Overview
Description
Lonza Group AG Unsponsored ADR is a financial asset that represents American Depository Receipts for Lonza Group AG, a prominent Swiss multinational company. The primary function of an ADR is to facilitate investment in foreign companies by enabling them to be traded on U.S. exchanges, simplifying investor access and broadening the company's shareholder base. Lonza Group AG operates in the life sciences sector, providing a range of products and services, including pharmaceuticals, biotechnology, and specialty chemicals. The unsponsored ADRs enable investors to gain exposure to Lonza's performance without having to directly trade on international stock exchanges, offering an accessible option to diversify their portfolios with foreign equities. Lonza's significance in the financial market is underscored by its extensive contributions to healthcare and pharmaceuticals, sectors that are critical to global economic stability and growth. The ADRs thus play a key role in connecting international investors with influential global companies like Lonza Group.
About
CEO
Mr. Albert M. Baehny
Employees
19299
Address
Muenchensteinerstrasse 38
Basel, 4002
Basel, 4002
Phone
41 61 316 81 11
Website
Instrument type
American depositary receipt
Sector
Healthcare
Industry
Diagnostics & Research
Country
Germany
MIC code
XDUS